Moleculin Biotech's Volatility, Explained By: Benzinga via Benzinga February 16, 2018 at 13:20 PM EST Moleculin Biotech Inc (NASDAQ: MBRX)’s good-news rally had a short life. The stock popped 55 percent Thursday after management ... Read More >> Related Stocks: Aytu Biopharma Inc Dare Bioscience Inc Moleculin Biotech CS